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CASE REPORT
X-linked myotubular myopathy (XLMTM) is a
congenital condition, which was initially thought
to be caused by arrest of muscle fiber maturation
during myotubular development at 8–15 weeks
of gestation.1 However, further investigation has
revealed that these structures are not genuine
myotubes, but rather mature fibers that are path-
ologically altered. It is characterized histologically
by a row of central nuclei located within a core of
myocyte cytoplasm,2,3 with a cylinder made up
of contractile myofibrils around this core. MTM
can be inherited as an autosomal recessive, auto-
somal dominant, or X-linked disorder.2 XLMTM
usually affects male infants and has a severe phe-
notype that leads to early death. Female carriers
of the disorder have been reported to have slowly
progressive muscle weakness that begins in child-
hood.4 The genetic locus responsible for XLMTM
has been mapped to Xq28, where the MTM1 gene
encodes myotubularin protein, a phosphoinositol
3-phosphatase. Deficiency of this enzyme in MTM
affects the phosphatidylinositol 3-kinase and
phosphatidylinositol 3-phosphate pathway.5 We
report a case of XLMTM with a base pair muta-
tion change in exon 11 of the MTM1 gene
(1160C > A) inherited from the mother.
Case Report
A male infant was born prematurely to a 28-year-
old, gravida 1, para 1, healthy mother with poly-
hydramnios at 36 weeks’ gestation. The infant
was delivered spontaneously without perinatal
insult, but he was immediately noted to have
generalized hypotonia and cyanosis, and was not
crying or breathing spontaneously. He was resus-
citated and placed on mechanical ventilation.
The Apgar scores were 4 and 6 at 1 and 5 minutes,
respectively.
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On admission to the neonatal intensive care
unit, his temperature was 37.5°C, pulse was 
148 beats/min, respiration was 36 breaths/min 
(ventilator-dependent), and blood pressure was
60/24 mmHg. His birth weight was 2414 g (50th
to 75th percentile), head circumference was
34.5 cm (75th to 90th percentile), and length was
51 cm (> 90th percentile). His face was elongated
with thin, narrow cheeks, and his mouth sagged
open due to weak masseters (Figure 1A). He was
generally hypotonic and had arachnodactyly of
both hands and feet (Figures 1B and 1C). There
was bilateral ptosis, a high-arched palate, and 
inverted V-shaped upper lips. There was a cephalo-
hematoma, and the baby had less temporal mus-
cle mass than normal. Lung examination was
normal. Auscultation of the heart revealed a grade
II/VI systolic murmur at the left lower sternal
border. The abdomen was soft and flat, the scro-
tum small, and the testes undescended. A com-
plete blood count, blood sugar, serum electrolytes,
aspartate aminotransferase, alanine aminotrans-
ferase, blood urea nitrogen, creatinine, creatine
kinase, lactate, pyruvate, carnitine, and tandem
mass spectrometry were all within normal limits.
Chest X-ray revealed thin ribs and clavicles
(Figure 2). Brain ultrasonography showed bilat-
eral subependymal cysts. Ultrasonography of the
abdomen, heart, and muscles showed no specific
abnormalities. The child’s karyotype was 46XY.
The parents denied any family history of neuro-
muscular disease, although on the maternal side,
there was a history of cleft lip and birth asphyxia.
The neonate had frequent episodes of bilat-
eral atelectasis, and aspiration pneumonia was
present on admission to the intensive care unit.
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Figure 1. (A) The face is elongated with thin, narrow cheeks and decreased temporal muscle mass. (B, C) Both the upper
and lower extremities have arachnodactyly.
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He was extubated at 16 days of age but had to be
re-intubated 6 days later because of respiratory
distress secondary to atelectasis. Weaning was
again attempted when he was 2 months, 11 days
old. However, he had frequent episodes of bra-
dycardia and cyanosis and had to be intubated
12 days later. Tracheostomy and gastrostomy were
performed when he was 3 months old.
Light microscopy of tissue from a muscle
biopsy performed on the second day after birth
was consistent with MTM (Figure 3A), a diagnosis
confirmed by electron microscopy (Figure 4). We
used nicotinamide adenine dinucleotide tetrazo-
lium reductase (NADH-TR) (Figure 3B) and mod-
ified Gomori’s trichrome stains to differentiate
his disorder from other neuromuscular diseases.
All 14 coding exons of the MTM1 gene from the
patient’s genomic DNA were amplified and se-
quenced by polymerase chain reaction in both for-
ward and reverse directions. This revealed a single
substitution at nucleotide 1160 of exon 11 (c.1160
C > A), which resulted in a serine-to-tyrosine
Figure 2. Chest X-ray shows thin ribs and clavicles.
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Figure 3. (A) Muscle biopsy specimen with moderate variation in fiber size, ranging from 5 μm to 15 μm. Almost all the
fibers are small and round. No necrotic or regenerating fibers are seen. The amount of interstitial connective tissue is
mildly increased. The nuclei are large and centrally placed (as the arrow indicates), and comprised about 35% of cell 
volume (hematoxylin & eosin, 250×). (B) Differentiation from central core disease. Most fibers have a peripheral halo,
which indicates aggregation of oxidative enzyme activity in the center of the muscle fibers (as the arrow indicates).
(NADH-TR, 250×).
Figure 4. Electron micrograph of longitudinal section shows
muscle fibers with centrally placed nuclei (7000×).
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change at amino acid position 387 (p.S387Y mu-
tation) in the gene product, the apparent cause
of the patient’s MTM (Figure 5). Deletion analy-
sis of the 5-untranslated exon (exon 1) of the
MTM1 gene was also performed, but no deletion
was detected. DNA sequencing of the parents
was performed, and the mother was found to
carry the same mutation (Figure 6).
Discussion
We report the case of a male Taiwanese neonate
with MTM. Genetic analysis revealed this to be
the X-linked form caused by a mutation in exon
11 of the MTM1 gene. Congenital myopathy
should be considered in any infant with respira-
tory failure and ventilator dependency at birth.
Severe perinatal MTM has to be considered in
male fetuses and newborns with polyhydramnios
and respiratory failure, or in infants who have
died of unexplained postnatal asphyxia.6
MTM can be inherited as an autosomal reces-
sive, autosomal dominant, or X-linked disorder.
Wallgren-Pettersson et al7 reported that the auto-
somal dominant form mostly has a later onset
and milder course than the X-linked form, and
the autosomal recessive form is intermediate in
both respects. The prognosis in the X-linked
form is not always poor, and survival into adult-
hood cannot be regarded as proof of autosomal
inheritance.
In a review by Bruyland et al,8 death secondary
to respiratory failure occurred in 26 of 38 baby
boys in seven families with XLMTM. A detailed
family history,9 muscle biopsy, specific histochem-
ical staining, electron microscopy, and DNA analy-
sis may all contribute to the definitive diagnosis
in a hypotonic newborn with respiratory distress
at birth.10
Heckmatt et al3 reported eight unrelated chil-
dren with MTM; facial diplegia was present in all
eight and external ophthalmoplegia in six. These
findings are similar to those in congenital myo-
tonic dystrophy, but the mothers of infants with
that condition will invariably have mild facial
weakness and clinical myotonia. In our case, the
mother had a normal facial appearance. Keppen
et al11 found that polyhydramnios, as was present
in our case, is a common feature of congenital
myopathy because the swallowing muscles in the
fetus are weak.
Braga et al12 reported seven cases of MTM in
three families. They concluded that needle biopsy
of the muscle, which demonstrates an increased
number of centrally located nuclei with perinu-
clear halos, is an important tool for early diagno-
sis. The muscle histopathology in our case, with
Figure 5. A mutation that is a base pair change in exon 
11 of the MTM1 gene (1160C > A) was confirmed in the
patient.
Figure 6. Forward DNA sequencing for the mother also
showed a base pair change in exon 11 of the MTM1 gene
(1160C > A), as in the patient.
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central nuclei located within muscle fibers, was
consistent with the diagnosis of MTM.
Approximately 133 mutations in the MTM1
gene, located on Xq28, have been described as
the cause of XLMTM (OMIM 310400).2 Reported
mutations include missense, nonsense, and splice
site single base changes, as well as small and
large genomic rearrangements.13 The majority of
patients carry a truncating or missense mutation
in MTM1.14 While most truncating mutations
cause the severe and early lethal phenotype, mis-
sense mutations are generally associated with
milder disease and prolonged survival (up to 54
years).2 The exception to this is missense muta-
tions that involve the phosphatase domain or
the SET (suvar 3–9, enhancer-of-zeste, trithorax)-
interacting domain.2,15,16 According to sequence
analysis, serine is the second amino acid from
the phosphatase active site, so it may lead to a se-
vere phenotype. A list of MTM1 gene mutations is
maintained at the Human Gene Mutation Database
(entry for XLMTM: http://www.uwcm.ac.uk/uwcm/
mg/search/119439.html). We found a new mis-
sense mutation in our patient that we do not 
believe has previously been reported.2 As noted
above, the base pair change in exon 11, c.1160C
> A, results in an amino acid change at position
387, p.S387Y, in the gene product. This is a non-
conservative amino acid change that affects an
evolutionarily conserved amino acid residue in 
a functionally conserved domain of the MTM1
protein.
DNA analysis showed the mother to be the
carrier, while the father was normal. As with other
X-linked disorders, if this couple were to have
another male baby, there is a 50% chance that he
would also have XLMTM. This illustrates the im-
portance of genetic analysis in such cases as an
aid to genetic counseling. According to Herman
et al,17 the presence of typical facial features and
long-term ventilatory dependence imply a severe
phenotype, therefore, the prognosis for this child
is poor. It is impossible on the basis of one case
to determine if this particular mutation invariably
results in a severe phenotype. However, molecular
studies such as this increase our understanding
of the pathophysiology of such disorders. Perhaps
someday, cumulative knowledge of the genetic
basis of congenital myopathy will contribute to
more than simply prognostic information.
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